DAP:ETR
Danaher Corp
€196.50
arrow_upward
+0.10%(+0.20) 1D
Set 28, 1:17:41 PM GMT+2 · EUR
search
Lahat ng simbolo
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Simbolo | Presyo | Palitan | % ng Pagbabago |
|---|
insights_autoBumubuo ng mga nangungunang insight para sa DAP...
Buksan
€194.25
Mataas
€197.00
Mababa
€193.65
Mkt. cap
157.81B
Avg. na dami
586.00
Dami
744.00
Mataas nang 52-wk
€208.30
Mababa nang 52-wk
€138.20
Bilang ng mga empleyado
59K
Buksan
€194.25
Mataas
€197.00
Mababa
€193.65
Mkt. cap
157.81B
Avg. na dami
586.00
Dami
744.00
Mataas nang 52-wk
€208.30
Mababa nang 52-wk
€138.20
Bilang ng mga empleyado
59K
Mga balita at kwento
Mula sa mga source sa web at partner sa balita
https://www.dars.gov.et/
·
1 buwan ang nakalipas
DHR Q2 2026 Earnings: EPS Beats Estimates with 4.68% Surprise on Resilient Execution - Forward EPS Estimate
https://www.dars.gov.et/
·
2 buwan ang nakalipas
Danaher Shares Slide on Reduced Guidance; 3M Stock Rises on Earnings Optimism - Estimate Dispersion
Profile
Danaher Corporation is an American healthcare company headquartered in Washington, D.C.. It develops products used for advances in biotechnology, life sciences, and diagnostics. The company operates three divisions: biotechnology, which develops products for the development of therapeutics; life sciences, which develops products to identify causes of disease, new therapies, and to test and manufacture new drugs, vaccines and gene editing technologies; and diagnostics, which develops instruments, consumables, and software and services to diagnose diseases. Danaher was founded in 1984 by brothers Steven Rales and Mitchell Rales; it was named after Danaher Creek in Western Montana, where the brothers came up with the idea for the company while fishing.
The company is ranked 180th on the Fortune 500 and 241st on the Forbes Global 2000. Wikipedia
Tungkol sa Danaher Corp